Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 558

    1.

    Meta-analysis: duration of first-line proton-pump inhibitor based triple therapy for Helicobacter pylori eradication.

    Fuccio L, Minardi ME, Zagari RM, Grilli D, Magrini N, Bazzoli F.

    Ann Intern Med. 2007 Oct 16;147(8):553-62.PMID: 17938394 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Strategy for retreatment of therapeutic failure of eradication of Helicobacter pylori infection.

    Nagahara A, Miwa H, Ohkura R, Yamada T, Sato K, Hojo M, Sato N.

    J Gastroenterol Hepatol. 2001 Jun;16(6):613-8.PMID: 11422612 [PubMed - indexed for MEDLINE]Related articles

    4.

    Comparison of the efficacy of 1-day high-dose quadruple therapy versus 7-day triple therapy for treatment of Helicobacter pylori infection.

    Zheng Q, Pan Y, Zhang L, Xiao SD.

    Chin J Dig Dis. 2005;6(4):202-5.PMID: 16246231 [PubMed - indexed for MEDLINE]Related articles

    5.

    Comparable Helicobacter pylori eradication rates obtained with 4- and 7-day rabeprazole-based triple therapy: a preliminary study.

    Gambaro C, Bilardi C, Dulbecco P, Iiritano E, Zentilin P, Mansia C, Usai P, Vigneri S, Savarino V.

    Dig Liver Dis. 2003 Nov;35(11):763-7.PMID: 14674665 [PubMed - indexed for MEDLINE]Related articles

    6.

    Eradication rates of helicobacter pylori infection with second-line treatment: non-ulcer dyspepsia compared to peptic ulcer disease.

    Chung SJ, Lee DH, Kim N, Jung SH, Kim JW, Hwang JH, Park YS, Lee KH, Jung HC, Song IS.

    Hepatogastroenterology. 2007 Jun;54(76):1293-6.PMID: 17629092 [PubMed - indexed for MEDLINE]Related articles

    7.

    Meta-analysis: sequential therapy appears superior to standard therapy for Helicobacter pylori infection in patients naive to treatment.

    Jafri NS, Hornung CA, Howden CW.

    Ann Intern Med. 2008 Jun 17;148(12):923-31. Epub 2008 May 19. Erratum in: Ann Intern Med. 2008 Sep 16;149(6):439. PMID: 18490667 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Systematic review and meta-analysis: proton pump inhibitor vs. ranitidine bismuth citrate plus two antibiotics in Helicobacter pylori eradication.

    Gisbert JP, Gonzalez L, Calvet X.

    Helicobacter. 2005 Jun;10(3):157-71. Review.PMID: 15904473 [PubMed - indexed for MEDLINE]Related articles

    9.

    Efficacy of metronidazole as second-line drug for the treatment of Helicobacter pylori Infection in the Japanese population: a multicenter study in the Tokyo Metropolitan Area.

    Matsuhisa T, Kawai T, Masaoka T, Suzuki H, Ito M, Kawamura Y, Tokunaga K, Suzuki M, Mine T, Takahashi S, Sakaki N.

    Helicobacter. 2006 Jun;11(3):152-8. Erratum in: Helicobacter. 2006 Aug;11(4):306. PMID: 16684262 [PubMed - indexed for MEDLINE]Related articles

    10.

    Levofloxacin-based triple therapy versus bismuth-based quadruple therapy for persistent Helicobacter pylori infection: a meta-analysis.

    Saad RJ, Schoenfeld P, Kim HM, Chey WD.

    Am J Gastroenterol. 2006 Mar;101(3):488-96.PMID: 16542284 [PubMed - indexed for MEDLINE]Related articles

    11.

    Comparison of 7-day and 14-day proton pump inhibitor-containing triple therapy for Helicobacter pylori eradication: neither treatment duration provides acceptable eradication rate in Korea.

    Kim BG, Lee DH, Ye BD, Lee KH, Kim BW, Kim SG, Kim SW, Kim SK, Kim JJ, Kim HY, Park JJ, Park CY, Baik GH, Lee YC, Lee JH, Lee JH, Chun HJ, Hahm KB, Hong SJ, Lee SW, Jung HC.

    Helicobacter. 2007 Feb;12(1):31-5.PMID: 17241298 [PubMed - indexed for MEDLINE]Related articles

    12.

    Seven versus ten days of rabeprazole triple therapy for Helicobacter pylori eradication: a multicenter randomized trial.

    Calvet X, Ducons J, Bujanda L, Bory F, Montserrat A, Gisbert JP; Hp Study Group of the Asociación Española de Gastroenterología.

    Am J Gastroenterol. 2005 Aug;100(8):1696-701.PMID: 16086704 [PubMed - indexed for MEDLINE]Related articles

    13.

    Second-line treatment for Helicobacter pylori infection in Japan: proton pump inhibitor-based amoxicillin and metronidazole regimen.

    Nagahara A, Miwa H, Kawabe M, Kurosawa A, Asaoka D, Hojo M, Iijima K, Terai T, Ohkusa T, Miyazaki A, Sato N.

    J Gastroenterol. 2004 Nov;39(11):1051-5.PMID: 15580397 [PubMed - indexed for MEDLINE]Related articles

    14.

    Systematic review and meta-analysis: is 1-week proton pump inhibitor-based triple therapy sufficient to heal peptic ulcer?

    Gisbert JP, Pajares JM.

    Aliment Pharmacol Ther. 2005 Apr 1;21(7):795-804. Review.PMID: 15801914 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Sequential therapy versus standard triple-drug therapy for Helicobacter pylori eradication: a randomized trial.

    Vaira D, Zullo A, Vakil N, Gatta L, Ricci C, Perna F, Hassan C, Bernabucci V, Tampieri A, Morini S.

    Ann Intern Med. 2007 Apr 17;146(8):556-63.PMID: 17438314 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    A meta-analysis of short versus long therapy with a proton pump inhibitor, clarithromycin and either metronidazole or amoxycillin for treating Helicobacter pylori infection.

    Calvet X, García N, López T, Gisbert JP, Gené E, Roque M.

    Aliment Pharmacol Ther. 2000 May;14(5):603-9.PMID: 10792124 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    One-week versus two-week H2-receptor antagonist in combination with amoxicillin and tinidazole for eradication of Helicobacter pylori infection.

    Hsu CC, Chen JJ, Hu TH, Lu SN, Changchien CS.

    Hepatogastroenterology. 2005 Sep-Oct;52(65):1617-21.PMID: 16201128 [PubMed - indexed for MEDLINE]Related articles

    18.

    The efficacy of bismuth containing quadruple therapy as a first-line treatment option for Helicobacter pylori.

    Uygun A, Kadayifci A, Safali M, Ilgan S, Bagci S.

    J Dig Dis. 2007 Nov;8(4):211-5.PMID: 17970879 [PubMed - indexed for MEDLINE]Related articles

    19.

    Tetracycline, metronidazole and amoxicillin-metronidazole combinations in proton pump inhibitor-based triple therapies are equally effective as alternative therapies against Helicobacter pylori infection.

    Matsushima M, Suzuki T, Kurumada T, Watanabe S, Watanabe K, Kobayashi K, Deguchi R, Masui A, Takagi A, Shirai T, Muraoka H, Kobayashi I, Mine T.

    J Gastroenterol Hepatol. 2006 Jan;21(1 Pt 2):232-6.PMID: 16460479 [PubMed - indexed for MEDLINE]Related articles

    20.

    Eradication of helicobacter pylori for non-ulcer dyspepsia.

    Moayyedi P, Soo S, Deeks J, Delaney B, Harris A, Innes M, Oakes R, Wilson S, Roalfe A, Bennett C, Forman D.

    Cochrane Database Syst Rev. 2000;(2):CD002096. Review. Update in: Cochrane Database Syst Rev. 2001;(1):CD002096. PMID: 10796858 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data